Comparison of direct oral anticoagulants and warfarin regarding midterm adverse events in patients with atrial fibrillation undergoing catheter ablation

BACKGROUND: Oral anticoagulants, including direct oral anticoagulants (DOACs), are usually required in atrial fibrillation (AF) patients who are at a high risk of thromboembolism (TE), even if they had undergone catheter ablation (CA). Although several studies have reported the safety and efficacy o...

Descripción completa

Detalles Bibliográficos
Autores principales: Sagawa, Yuichiro, Nagata, Yasutoshi, Yamaguchi, Tetsuo, Iwai, Takamasa, Yamaguchi, Junji, Hijikata, Sadahiro, Watanabe, Keita, Masuda, Ryo, Miyazaki, Ryoichi, Miwa, Naoyuki, Sekigawa, Masahiro, Hara, Nobuhiro, Nozato, Toshihiro, Hirao, Kenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6111475/
https://www.ncbi.nlm.nih.gov/pubmed/30167014
http://dx.doi.org/10.1002/joa3.12079

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6111475/
https://www.ncbi.nlm.nih.gov/pubmed/30167014
http://dx.doi.org/10.1002/joa3.12079

Ejemplares similares